Company expects the savings from these initiatives to be in the range
of $2-3 million on an annualized basis.
-- Receipt of Nasdaq Notification. On April 2, 2008, the Company received
written notification from Nasdaq that, as of December 31, 2007, the
Company was not in compliance with the minimum $10.0 million
stockholders' equity requirement for continued listing under
Marketplace Rule 4450(a)(3). As required by Nasdaq, the Company has
submitted a plan to achieve and sustain compliance with all of The
Nasdaq Global Market listing requirements and the time frame required
to complete that plan.
Conference Call and Webcast Information
Memory Pharmaceuticals will hold a conference call on May 14, 2008, at
9:00 a.m. EDT to discuss the Company's first quarter 2008 financial
results. The conference call will also be broadcast live from the
"Investors" section of the Company's website. Memory Pharmaceuticals'
senior management will host the conference call. Investors and other
interested parties may access the call as follows:
Date: Wednesday, May 14, 2008
Time: 9:00 a.m. EDT
Telephone (U.S.): 866.356.4441
Telephone (international): 617.597.5396
Participant Passcode: 80809977
Webcast: http://www.memorypharma.com under the
An audio replay of the conference call will be available from 11:00
a.m. EDT on Wednesday, May 14, 2008, until Wednesday, May 21, 2008. To
access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888
(international) and enter passcode number 14991737. An audio replay of the
conference call will also be available under the "Investors" section of the
|SOURCE Memory Pharmaceuticals Corp.|
Copyright©2008 PR Newswire.
All rights reserved